View in EDS HTML Full Text PDF Full Text

Phase I Clinical Trial of Islet Antigen–Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.

Saved in:
Bibliographic Details
Title: Phase I Clinical Trial of Islet Antigen–Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.
Authors: Greenbaum, Carla J.1 (AUTHOR), Long, S. Alice2 (AUTHOR), Gitelman, Stephen E.3 (AUTHOR), Gaglia, Jason L.4 (AUTHOR), Daniels, Mark5 (AUTHOR), Brusko, Todd M.6 (AUTHOR), Lord, Sandra1 (AUTHOR), Bundy, Brian N.7 (AUTHOR), Krischer, Jeffrey P.7 (AUTHOR) jpkrischer@epi.usf.edu, Haller, Michael J.8 (AUTHOR), Steck, Andrea K.9 (AUTHOR), DiMeglio, Linda A.10 (AUTHOR), Evans-Molina, Carmella10 (AUTHOR), Moran, Antoinette11 (AUTHOR), Prahalad, Priya12 (AUTHOR), Wilson, Darrell M.12 (AUTHOR), Russell, William E.13 (AUTHOR), Sherr, Jennifer L.14 (AUTHOR), Raskin, Philip15 (AUTHOR), Clements, Mark A.16 (AUTHOR)
Source: Diabetes. Mar2026, Vol. 75 Issue 3, p506-518. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00121797
DOI:10.2337/db25-0777